The trading price of Puma Biotechnology Inc (NASDAQ:PBYI) closed lower on Friday, May 23, and closing at $3.23, -0.46% lower than its previous close.
The company’s P/E ratio in the trailing 12-month period was 4.20. In examining the 52-week price action we see that the stock hit a 52-week high of $4.23 and a 52-week low of $2.22. Over the past month, the stock has gained 7.48% in value.
Puma Biotechnology Inc, whose market valuation is $160.58 million at the time of this writing, is expected to release its quarterly earnings report in June. Investors’ optimism about the company’s current quarter earnings report is understandable. Analysts have predicted the quarterly earnings per share to grow by 0.11 per share this quarter, however they have predicted annual earnings per share of 0.69 for current year and 0.5 for next year.
Analysts have forecast the company to bring in revenue of 52M for the current quarter, with the likely lows of 52M and highs of 52M. From the analysts’ viewpoint, the consensus estimate for the company’s annual revenue is 220M.
On the technical side, indicators suggest PBYI has a 100% Buy on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 75% Buy, while an average of long term indicators suggests that the stock is currently 100% Buy.
Here is the average analyst rating on the stock as represented by 1.00 to 5.00, with the extremes of 1.00 and 5.00 suggesting the stock should be considered as either strong buy or strong sell respectively. The number of analysts that have assigned PBYI a recommendation rating is 1. Out of them, 0 rate it a Hold, while 1 recommend Buy, whereas 0 assign an Overweight rating. 0 analyst(s) have tagged Puma Biotechnology Inc (PBYI) as Underweight, while 0 advise Sell. Analysts have rated the stock Buy, likely urging investors to take advantage of the opportunity to add to their holdings of the company’s shares.
A quick review shows that PBYI’s price is currently 2.41% off the SMA20 and 4.33% off the SMA50. The RSI metric on the 14-day chart is currently showing 52.48, and weekly volatility stands at 4.09%. When measured over the past 30 days, the indicator reaches 4.68%. Puma Biotechnology Inc (NASDAQ:PBYI)’s beta value is currently sitting at 1.28, while the Average True Range indicator is currently displaying 0.20.
To see how Puma Biotechnology Inc stock has been performing in comparison to its peers in the industry, here are the numbers: PBYI stock’s performance was -0.46% in the latest trading, and -22.42% in the past year. Puma Biotechnology Inc has a P/E ratio of 4.20.
An evaluation of the daily trading volume of Puma Biotechnology Inc (NASDAQ:PBYI) indicates that the 3-month average is 404.93K.
Currently, records show that 49.62 million of the company’s shares remain outstanding. The insiders hold 24.69% of outstanding shares, whereas institutions hold 56.06%. However, since the stock’s price has seen 6.07% year-to-date, investors’ interest is likely to be reignited due to its potential to move even higher.
